| Tadeusz Robak, MD, PhD – Conference Chair Medical University of Łódź Łódź, Poland |
Wojciech Jurczak, MD, PhD Maria Sklodowska Curie Institute of Oncology Kraków, Poland |
|
| Krzysztof Giannopoulos, MD, PhD, DSc Medical University of Lublin Lublin, Poland |
Ewa Maranda, MD, PhD Institute of Hematology and Transfusion Medicine Warsaw, Poland |
|
| Iwona Hus, MD, PhD, DSc Institute of Hematology and Transfusion Medicine Warsaw, Poland |
Aleksander B. Skotnicki, MD, PhD Jagiellonian University Kraków, Poland |
|
| Krzysztof Jamroziak, MD, PhD Institute of Hematology and Transfusion Medicine Warsaw, Poland |
||
| Tadeusz Robak, MD, PhD – Conference Chair Medical University of Łódź Łódź, Poland |
Thomas Kipps, MD, PhD UC San Diego, Moores Cancer Center La Jolla, California, United States |
|
| Jennifer Brown, MD, PhD Dana-Farber Cancer Institute Boston, Massachusetts, United States |
Carsten U. Niemann, MD Rigshospitalet, Copenhagen University Hospital Copenhagen, Denmark |
|
| Nicholas Chiorazzi, MD The Feinstein Institute for Medical Research Manhasset, New York, United States |
Susan O’Brien, MD University of California, Irvine Orange, California, United States |
|
| Matthew Davids, MD, MMSc Dana-Farber Cancer Institute Boston, Massachusetts, United States |
Sarka Pospisilova, PhD Masaryk University Brno, Czech Republic |
|
| Barbara Eichhorst, MD University of Cologne Cologne, Germany |
Anna Schuh, MD, PhD, MRCP, FRCPath University of Oxford Oxford, United Kingdom |
|
| Paolo Ghia MD, PhD Università Vita Salute San Raffaele and IRCCS Istituto Scientifico San Raffaele Milano, Italy |
John Seymour, MBBS, PhD Peter MacCallum Cancer Centre Melbourne, Australia |
|
| Gianluca Gaidano, MD, PhD University of Eastern Piedmont Novara, Italy |
Tamar Tadmor, MD Technion-Israel Institute of Technology Haifa, Israel |
|
| Michael Hallek, MD, PhD University Hospital of Cologne, German CLL Study Group Cologne, Germany |
William Wierda, MD, PhD The University of Texas MD Anderson Cancer Center Houston, Texas, United States |
|
| Iwona Hus, MD, PhD, DSc Department of Hematology National Medical Institute Ministry of Interior and Administration, Warsaw, Poland |
Jennifer Woyach, MD The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States |
|
| Arnon Kater, MD, PhD Amsterdam University Medical Centers Amsterdam, Netherlands |
Catherine Wu, MD Dana-Farber Cancer Institute Boston, Massachusetts, United States |
| Bartosz Pula, MD, PhD – YIM Committee Chair Institute of Hematology and Transfusion Medicine Warsaw, Poland |
Elisa ten Hacken, PhD Weill Medical College of Cornell University New York, New York, United States |
|
| Moritz Fürstenau, MD Department I of Internal Medicine Faculty of Medicine and University Hospital Cologne, University of Cologne Cologne, Germany |
Marek Mråz, PhD Masaryk University Brno, Czech Republic |
|
| Emanuela Ghia, PhD Moores Cancer Center University of California San Diego La Jolla, CA, United States |
Philip Thompson, MBBS Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne Melbourne, Australia |
| Jennifer Brown, MD, PhD Dana-Farber Cancer Institute Boston, Massachusetts, United States |
Emili Montserrat, MD Hospital Clínic, University of Barcelona Barcelona, Spain |
|
| John Byrd, MD The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States |
Carol Moreno, MD, PhD Hospital de la Santa Creu i Sant Pau Barcelona, Spain |
|
| Federico Caligaris-Cappio, MD Fondazione AIRC Milan, Italy |
Susan O’Brien, MD Chao Family Comprehensive Cancer Center, University of California Orange, California, United States |
|
| Nicholas Chiorazzi, MD The Feinstein Institute for Medical Research Manhasset, New York, United States |
Kanti R. Rai, MD UCI Health Chao Family Comprehensive Cancer Center Orange, California, United States |
|
| Carlo Croce, MD The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States |
Tadeusz Robak, MD, PhD Medical University of Łódź Łódź, Poland |
|
| Guillermo Dighiero, MD, PhD Pasteur Institute of Montevideo Montevideo, Uruguay |
Davide Rossi, MD, PhD Oncology Institute of Southern Switzerland Bellinzona, Switzerland |
|
| Hartmut Döhner, MD University of Ulm Ulm, Germany |
Anna Schuh, MD, PhD, MRCP, FRCPath University of Oxford Oxford, United Kingdom |
|
| Barbara Eichhorst, MD University of Cologne Cologne, Germany |
John Seymour, MBBS, PhD Peter MacCallum Cancer Centre Melbourne, Australia |
|
| Paolo Ghia, MD, PhD Università Vita Salute San Raffaele and IRCCS Istituto Scientifico San Raffaele Milan, Italy |
Tait Shanafelt, MD Stanford Medical Center Palo Alto, California, United States |
|
| John Gribben, MD, DSc Barts Cancer Institute London, United Kingdom |
Stephan Stilgenbauer, MD University of Ulm Ulm, Germany |
|
| Michael Hallek, MD University Hospital of Cologne, German CLL Study Group Cologne, Germany |
William Wierda, MD, PhD The University of Texas MD Anderson Cancer Center Houston, Texas, United States |
|
| Peter Hillmen, MB ChB, PhD The Leeds Teaching Hospitals, St. James’s University Leeds, United Kingdom |
Jennifer Woyach, MD The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States |
|
| Michael Keating, MD, BS The University of Texas MD Anderson Cancer Center Houston, Texas, United States |
Catherine Wu, MD Dana-Farber Cancer Institute Boston, Massachusetts, United States |
|
| Thomas Kipps, MD, PhD UC San Diego, Moores Cancer Center La Jolla, California, United States |
